Find a TAVR Center
Free Info Kit
Doctor Discussion Guide

Share with friends

Close

Legal Terms

Please Read this Terms of Use Agreement and Privacy Policy Carefully Before Using These Sites

By using these Sites, you signify your assent to these Terms of Use. If you do not agree to these Terms of Use, please do not use these Sites. This Terms of Use Agreement may be updated by us from time to time without notice to you. You can review the most current version of this Agreement at any time at: www.newheartvalve.com/terms

In addition, when using particular Edwards Lifesciences services or participating in the events, you and Edwards Lifesciences shall be subject to any posted guidelines, additional terms or rules applicable to such services or events. All such guidelines or rules are hereby incorporated by reference into the Agreement.

Copyrights and Trademarks

All materials and images used on lifeisnow.com or any website owned, operated, licensed or controlled by Edwards Lifesciences ("Sites") are owned or licensed by Edwards Lifesciences Corporation. You are hereby given permission to download and/or print a copy of information or the materials from these Sites for your non-commercial use only provided that any such copy keeps intact all copyright and other proprietary notices and any disclaimers contained therein. Except as specifically provided to the contrary in this Agreement, no material from these Sites may be copied, reproduced, republished, uploaded, posted, transmitted, mirrored, hyperlinked or distributed in any way. Modification of the materials or use for any other purpose is (i) a violation of Edwards Lifesciences' copyright and other proprietary rights, (ii) expressly prohibited by law, and (iii) may result in civil and criminal penalties. Please be advised that Edwards Lifesciences aggressively enforces its intellectual property rights to the fullest extent of the law.

The design, layout and elements of the Sites are protected by trademark, trade dress, copyright and other laws and may not be copied or imitated in whole or in part. No logo, graphic, sound or image from the Sites may be copied or retransmitted unless expressly permitted in writing by Edwards Lifesciences. Nothing contained herein shall be construed as conferring any license or right under any Edwards Lifesciences Corporation patent, copyright or trademark.

Names, marks and logos associated with Edwards Lifesciences' products and services are either trademarks or registered trademarks of Edwards Lifesciences Corporation. The list of Edwards Lifesciences' trademarks, including the marks registered in the U.S. Patent and Trademark Office, may be accessed in the "Listing" link on the left navigation on this page. The use or misuse of these trademarks, except as permitted herein, is expressly prohibited and may be in violation of copyright, trademark, communications, and other state and federal laws. The list of Edwards Lifesciences' trademarks may be updated from time to time, as appropriate.

Trademarks Information

Edwards, Edwards Lifesciences, the stylized E logo, 1-800-4-A-Heart, 1-800-Fogarty, Advanced Venous Access, Acumen, AFM, Alterra, AMC Thromboshield, Anastaflo, Ascendra, Ascendra2, Ascendra 3, Ascendra+, AUTHORITY, AutoIncisor, AVA 3Xi, AVA HF, AViD, Axela, BMEYE, CADENCE, CADENCE-MIS, CardiAQ, CardiAQ-Edwards, Cardioband, CardioCare, Cardiocath, Carpentier-Edwards, Carpentier-Edwards Classic, Carpentier-Edwards Physio, Carpentier-Edwards Physio II, Carpentier-Edwards S.A.V., Carpentier-McCarthy-Adams IMR ETlogix, ccNexfin, CCOmbo, CCOmbo EDV, CCOmbo V, CENTERA, Certitude, Chandler, Clarity in Every Moment, ClearSight, ClearSight IQ, COMMENCE, COM-1, COM-2, COMPASSION, COMPASSION S3, COMPASSION XT, Connected Insights, ControlCath, Corkscrew, CO-Set, CO-Set+, Cosgrove-Edwards, Cribier-Edwards, DataSphere, Dedicated to Brighter Futures, dETlogix, Dispersion, Duraflex, DualFit, Duraflo, Edwards CENTERA, Edwards Commander, Edwards Critical Care System, Edwards eSheath, Edwards Essence, Edwards FloTrac, Edwards Fortis, Edwards Helio, EDWARDS INTUITY, EDWARDS INTUITY Elite, Edwards Master of Valve Therapy, Edwards MC3, Edwards NanoClip, Edwards PatientConnect, Edwards Prima Plus, Edwards Protection Cannulae, Edwards SAPIEN, Edwards SAPIEN XT, Edwards SAPIEN 3, Edwards SAPIEN 3 Ultra, Edwards Ultra, EMBOL-X, EMBOL-X Glide, Embrella, EndoClamp, EndoDirect, EndoPlege, EndoReturn, EndoVent, Enhanced Surgical Recovery Program and Design, Ergonic, eSheath, ESR, EverClip, EverGrip, Every Heartbeat Matters, EVOQUE, EV1000, EZ Glide, Fem-Flex, Fem-Flex II, FemTrak, Flex-Tip, FLOtector, FloTrac, FloTrac IQ, Fogarty, Fogarty Corkscrew, Fogarty Fortis, Fogarty Hydragrip, FORMA, Fortis, FOUNDATION, GeoForm, GlucoClear, Heart Master, HemoSphere, Hi-Shore, HPI, Hydrajaw, Hypotension Probability Indicator, IMR ETlogix, INSPIRIS, INSPIRIS RESILIA, Intellicath, IntraClude, Intro-Flex, iProctor, Janke-Barron, KONECT, Life is Now, Magna, Magna Ease, Magna Mitral Ease, Master of Valve Therapy, MC3, MC3 Tricuspid, MDOCK, Miller, Multi-Med, Myxo ETlogix, NanoClip, Neutralogic, newheartvalve.com, newheartvalve.com design logo, Nexfin, Nexfin CO-Trek, NovaFlex, NovaFlex+, OptiClip, OptiSite, Paceport, PARTNER, PARTNER II, PARTNER 3, PARTNER design logo, PASCAL, PATRIOT, PediaSat, PERI, PeriMap, PERIMOUNT, PERIMOUNT Magna, PERIMOUNT Plus, PERIMOUNT Theon, PeriVue, Physio, Physio II, Physio Tricuspid, Physiocal, PORT ACCESS, PORT ACCESS MVR, PreSep, ProPlege, Qualcrimp, QuickDraw, REF-1, REF/OX, RESILIA, Retractaguard, RetroFlex, RetroFlex II, RetroFlex 3, Retroplegia, Retroplegia II, RF3, SAPIEN, SAPIEN XT, SAPIEN 3, SAPIEN 3 Ultra, SAT-1, SAT-2, S.A.V., Safejaw, SDA, SoftClamp, Softjaw, Starr-Edwards, SVVxtra, Swan, Swan-Ganz, Swan-Ganz IQ, S3, TAVRbyEdwards.com, TFX, Theon, ThermaFix, Thin-Flex, ThruPort, Time-in-Target, TRANSFORM, Tricentrix, Trim-Flex, TruCal, TruClip, TruSite, True-Size, TRUE-SIZE, TruWave, TruWave IQ, Valtech, Valtech Cardio, ValveNet, ValvePoint, VAMP, VAMP Flex, VAMP Jr., VAMP Plus, Vantex, Vascushunt, Vascushunt II, VFit, Vigilance, Vigilance II, Vigileo, VIP, VIP+, VisuFlo II, VolumeView, and XenoLogiX are trademarks or service marks of Edwards Lifesciences Corporation or its affiliates.

Disclaimers

These Sites may contain information relating to various medical, health and fitness conditions and their treatment. This is for informational purposes only and is not meant to be a substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a medical, health or fitness condition or disease. You should always consult your own physician and medical advisors.

Although Edwards Lifesciences may from time to time monitor or review the Content posted in the Forums on its Sites, Edwards Lifesciences is under no obligation to do so and assumes no responsibility or liability arising from the Content contained in its Sites, or for any error, defamation, libel, slander, omission, falsehood, obscenity, pornography, profanity, danger or inaccuracy contained in any information within its Sites.

Edwards Lifesciences provides the contents of its Sites for informational purposes and for general interest and entertainment only. The materials and related graphics published on the Sites or accessed via the Sites could include technical inaccuracies or typographical errors. By using the Sites, you agree not to rely on any of the information contained herein.

THE INFORMATION ON THESE SITES IS PROVIDED "AS IS" AND EDWARDS LIFESCIENCES MAKES NO REPRESENTATIONS OR WARRANTY THAT THE INFORMATION CONTAINED ON THESE SITES WILL BE TIMELY OR ERROR-FREE. EDWARDS LIFESCIENCES AND/OR ITS RESPECTIVE SUPPLIERS MAKE NO REPRESENTATIONS OR WARRANTY ABOUT THE SUITABILITY OF THE INFORMATION CONTAINED IN THE MATERIALS AND RELATED GRAPHICS PUBLISHED, OR ANY PRODUCTS OR SERVICES OFFERED OR REFERRED TO, ON THESE SITES FOR ANY PURPOSE, INCLUDING WITHOUT LIMITATION, ANY MEDICAL, MEDICAL TESTING, HEALTH OR FITNESS PURPOSE. ALL SUCH MATERIALS, RELATED GRAPHICS, PRODUCTS OR SERVICES ARE PROVIDED "AS IS" AND WITHOUT WARRANTY OF ANY KIND.

EDWARDS LIFESCIENCES AND/OR ITS RESPECTIVE SUPPLIERS DISCLAIM ALL WARRANTIES AND CONDITIONS WITH REGARD TO SUCH INFORMATION, PRODUCTS AND SERVICES, INCLUDING ALL IMPLIED WARRANTIES AND CONDITIONS OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE AND NON-INFRINGEMENT. IN NO EVENT SHALL EDWARDS LIFESCIENCES BE LIABLE FOR ANY SPECIAL, DIRECT, INDIRECT OR CONSEQUENTIAL DAMAGES OR ANY OTHER DAMAGES WHATSOEVER, WHETHER IN AN ACTION IN CONTRACT, TORT OR OTHER ACTION, ARISING OUT OF OR IN CONNECTION WITH THE INFORMATION, MATERIALS, PRODUCTS, OR PROVISION OF OR FAILURE TO PROVIDE SERVICES AVAILABLE ON THESE SITES.

Links to Third Party Sites

The links on our Sites will allow you to leave our Sites and transfer to sites that are not under the control of Edwards Lifesciences. Edwards Lifesciences is not responsible for the contents of any linked site or any links contained in a linked site, or any changes or updates to such sites. Edwards Lifesciences is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by Edwards Lifesciences of the site.

Submissions

Edwards Lifesciences Corporation appreciates hearing from its customers, however, our policy does not allow us to accept or consider creative ideas, suggestions, inventions or materials other than those we have specifically requested. Accordingly, we must insist that you do not send us any such original creative materials. If, despite our request that you not send us any creative materials, you send us ideas, notes, inventions, concepts or other information ("Disclosures"), none of such Disclosures shall be subject to any obligation of confidence on the part of Edwards Lifesciences and Edwards Lifesciences shall not be liable for any use or disclosure of any Disclosures.

No confidential relationship shall be established in the event that any user of these Sites should make any oral, written or electronic response to Edwards Lifesciences Corporation (such as feedback, questions, comments, suggestions, ideas, etc.). Such response and any information submitted therewith shall be considered non-confidential and Edwards Lifesciences shall be free to reproduce, publish or otherwise use such information for any purposes, including without limitation, the research, development, manufacture, use or sale of products incorporating such information.

Forward Looking Statements

Certain portions of these Sites may include forward-looking statements that involve risks and uncertainties that could cause actual results or experience to differ materially from historical results or those anticipated. Actual future results may differ materially depending on a variety of factors, including technological advances in the medical field, foreign currency exchange rates, product demand and market acceptance, the impact of competitive products and pricing, the effect of economic conditions, and other risks detailed in Edwards Lifesciences' filings with the Securities and Exchange Commission. All forward-looking statements are based on estimates and assumptions made by management of the company as of the date of publication.

Applicable Laws

These Sites are controlled and operated from the United States of America and Edwards Lifesciences makes no representations that materials in the Sites are appropriate or available for use in other locations. These Sites contain information about products which may or may not be available in any particular country, may be available under different trademarks or names and, if applicable, may have received approval or market clearance by a governmental regulatory body for sale or use with different indications and restrictions in different countries. Each country has specific laws, regulations and medical practices governing the communication of medical information and information about medical products on Internet. You should not construe anything on these Sites as a promotion or solicitation for any product or for the use of any product that is not authorized by the laws and regulations of the country where you are located.

These Sites may link to other sites produced by Edwards Lifesciences' various operating divisions and subsidiaries. Those sites may have information that is appropriate only to the particular originating country or region where the site is based.

Actions in Response to Intellectual Property Infringement

It is the policy of Edwards Lifesciences to respect intellectual property rights of others. Edwards Lifesciences will process and investigate notices of alleged infringement and will take appropriate actions under the Digital Millennium Copyright Act, Title 17, United States Code, Section 512(c)(2) ("DMCA") and other applicable intellectual property laws.

Pursuant to the DMCA, notifications of claimed copyright infringement should be sent to a Service Provider's Designated Agent. Notification must be submitted to the following Designated Agent for these sites:

Service Provider(s): Edwards Lifesciences Corporation

Name of Agent Designated to Receive Notification of Claimed Infringement: Nolan Taira

Full Address of Designated Agent to Which Notification Should Be Sent:

Attn: Nolan Taira
Edwards Lifesciences Corporation
One Edwards Way
Irvine, CA 92614

Telephone Number of Designated Agent:
949-250-2500

Facsimile Number of Designated Agent:
949-250-2733

E-mail Address of Designated Agent:
nolan_taira@edwards.com

To be effective, the notification must be a written communication that includes the following:

A physical or electronic signature of a person authorized to act on behalf of the owner of an exclusive right that is allegedly infringed

Identification of the copyrighted work claimed to have been infringed, or, if multiple copyrighted works at a single online site are covered by a single notification, a representative list of such works at that site

Identification of the material that is claimed to be infringing or to be the subject of infringing activity and that is to be removed or access to which is to be disabled, and information reasonably sufficient to permit the service provider to locate the material

Information reasonably sufficient to permit the service provider to contact the complaining party, such as an address, telephone number, and, if available, an electronic mail address at which the complaining party may be contacted

A statement that the complaining party has a good-faith belief that use of the material in the manner complained of is not authorized by the copyright owner, its agent, or the law

Content Posted to Edwards Lifesciences' Sites

Certain areas on our Sites may enable you to access on-line forums or message boards where you can post messages and read messages posted by other users ("Forums"). Edwards Lifesciences is not responsible for and does not endorse any information, data, text, software, music, sound, photographs, graphics or other materials, including without limitation any information relating to procedures or applications which are not approved by the Food and Drug Administration (i.e. off-label uses) ("Content") submitted to us or posted on such Forums by Site users. By posting Content on the Sites, however, you grant Edwards Lifesciences a world-wide, royalty free, non-exclusive and fully sublicenseable right and license to reproduce, modify, publish, translate and otherwise use such Content for any purpose Edwards Lifesciences chooses, commercial, public or otherwise without compensation whatsoever.

You agree to be fully responsible for your own postings and agree to access and use the Forums at your own risk on an as-is basis. While Edwards Lifesciences has no obligation to monitor the Forums, it may, from time to time, monitor the Forums to determine whether postings comply with this Agreement, to guide the discussion on the Forums, or for other reasons. Edwards Lifesciences cannot and does not guarantee that it will post or continue to post every message or other Content that you or others submit to the Forums. Edwards Lifesciences reserves the right to edit or abridge postings for any reason and to disclose any information as necessary to satisfy any applicable law, regulation, legal process or government request, or to edit, refuse to post or to remove any information or materials, in whole or part, in Edwards Lifesciences' sole discretion.

You must abide by the following rules in connection with your use of the Forums:

You agree to post only messages that relate to the subject matter of the Forum.

You agree not to defame, abuse, harass, stalk, threaten or otherwise violate the legal rights of others. You agree not to impersonate any person or entity, including, for example, an Edwards Lifesciences employee or officer, a Forum leader, or falsely state or otherwise misrepresent your affiliation with a person or entity.

You agree not to post messages that contain material that is inappropriate, profane, pornographic, threatening, defamatory, inflammatory, infringing, obscene, or indecent or that could constitute or encourage conduct that would be considered a criminal offense, give rise to civil liability, or would otherwise violate the law. This includes any Content that infringes any patent, trademark, trade secret, copyright or other proprietary rights of any third party.

You agree to give attribution to others when you quote or paraphrase materials owned by others, and to limit your quotations to no more than 50 words.

You agree not to upload files, or cause others to upload files, that contain viruses, corrupted files, or any other similar software or programs that may adversely affect the operation of another’s computer.

You agree not to advertise or promote any goods or services in the Forums. This includes, among other things, “contests,” “junk mail”, “spam”, “chain letters”, and “pyramid schemes.”

You agree to indemnify and hold Edwards Lifesciences harmless from and against any claim or demand, including reasonable attorneys’ fees, made by any third party due to or arising out of Content you submit, post or transmit through Edwards Lifesciences’ sites, your use of the Sites, or your violation of any rights of another.

TAVR Hospital Finder / Doctor Locator

This directory is compiled from a variety of sources, including self-reported information provided by health care providers. Edwards also lists treatment centers that have aquired the relevant technologies, but Edwards recommends that you verify that the technology has been deployed and is being used clinically at a given treatment center, and that the treatment modality of interest is applicable to your diagnosis. Please contact the health care providers directly to obtain this information. Although Edwards undertakes reasonable efforts to keep the information contained in the directory listing accurate, Edwards does not warrant the accuracy, completeness, timeliness, merchantability or fitness for a particular purpose of the information contained in the directory listing. Edwards does not in any way endorse the health care providers or centers described in the directory listing, nor does Edwards verify medical qualifications, licenses, practice areas or suitability of the listed health care centers in order to provide this directory listing. To ensure that the information provided is accurate, call the provider. Patients should also ask whether the provider accepts their insurance and should contact their insurance providers to determine whether coverage is available before pursuing treatment. Edwards makes no representations about insurance coverage. To determine whether a treatment described herein is right for you, contact your medical professional. In no event shall Edward be liable to you or anyone else for any decision made or action taken by you in reliance on such information provided herein. Any damages or expenses of any kind, for any reason, shall be limited to the amount paid to access this directory listing.

Miscellaneous

This agreement shall be governed by and construed in accordance with the laws of the State of California, without giving effect to any principles of conflicts of law. If any provision of this agreement shall be deemed unlawful, void, or for any reason unenforceable, then that provision shall be deemed severable from this agreement and shall not affect the validity and enforceability of any remaining provisions.

Important Risk Information

Indications: The Edwards SAPIEN 3 transcatheter heart valve (THV), model 9600TFX, and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease...

  • Important Risk Information for Patients

    EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE

    Indications: The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a Heart Team, including a cardiac surgeon, to be at intermediate or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 3% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

    Contraindications (Who should not use): The Edwards SAPIEN 3 transcatheter heart valve and delivery system should not be used in patients who:

    • Cannot tolerate medications that thin the blood or prevent blood clots from forming.
    • Have an active infection in the heart or elsewhere.

    Warnings:

    • There may be an increased risk of stroke in transcatheter aortic valve replacement procedures, compared to other standard treatments for aortic stenosis in the high or greater risk population.
    • If an incorrect valve size for your anatomy is used, it may lead to heart injury, valve leakage, movement, or dislodgement.
    • Patients should talk to their doctor if they have significant heart disease, a mitral valve device or are allergic to chromium, nickel, molybdenum, manganese, copper, silicon, and/or polymeric materials.
    • The SAPIEN 3 valve may not last as long in patients whose bodies do not process calcium normally.
    • During the procedure, your doctors should monitor the dye used in the body; if used in excess it could lead to kidney damage. X-ray guidance used during the procedure may cause injury to the skin, which may be painful, damaging, and long-lasting.
    • Transcatheter aortic heart valve patients should take medications that thin the blood or prevent blood clots from forming, except when likely to have an adverse reaction, as determined by their physician. The Edwards SAPIEN 3 transcatheter heart valve has not been tested for use without medications that thin the blood or prevent blood clots from forming.

    Precautions: The long-term durability of the Edwards SAPIEN 3 transcatheter heart valve is not known, at this time. Regular medical follow-up is recommended to evaluate how well a patient’s heart valve is performing. For patients who have previously had aortic valve replacement, the safety, effectiveness, and durability of putting a transcatheter valve in an already implanted artificial valve are not known at this time.

    The safety and effectiveness of the transcatheter heart valve is also not known for patients who have:

    • An aortic heart valve that is not calcified, contains only one or two leaflets, has leaflets with large pieces of calcium that may block the vessels that supply blood to the heart or in which the main problem is that the valve leaks
    • Previous heart valve replacement or repair
    • A heart that does not pump well, has thickening of the heart muscle, with or without blockage, unusual ultrasound images of the heart that could represent irregularities such as a blood clot, a diseased mitral valve that is calcified or leaking, or Gorlin syndrome, a condition that affects many areas of the body and increases the risk of developing various cancers and tumors
    • Low white, red or platelet blood cell counts, or history of bleeding because the blood does not clot properly
    • Diseased or irregularly shaped vessels leading to the heart. Vessels in the legs which are heavily diseased or too small for associated delivery devices, or a large amount of calcification at the point of entry to the heart
    • Allergies to blood-thinning medications or dye injected during the procedure

    Potential risks associated with the procedure include:

    • Death, stroke, paralysis (loss of muscle function), permanent disability, or severe bleeding
    • Risks to the heart, including heart attack or heart failure, a heart that does not pump well, irregular heartbeat that may result in a need for a permanent pacemaker, chest pain, heart murmur, false aneurysm, recurring aortic stenosis(narrowing), too much fluid around the heart
    • Risks to your lungs or breathing, including difficulty breathing, fainting, buildup of fluid in or around the lungs, weakness or inability to exercise
    • Risks involving bleeding or your blood supply, including formation of a blood clot, high or low blood pressure, limited blood supply, a decrease in red blood cells, or abnormal lab values, bleeding in the abdominal cavity, collection of blood under the skin
    • Additional risks, including life-threatening infection, dislodgement of calcified material, air embolism (air bubbles in the blood vessels), poor kidney function or failure, nerve injury, fever, allergic reaction to anesthesia or dye, reoperation, pain, infection or bleeding at incision sites, or swelling

    Additional potential risks specifically associated with the use of the heart valve include:

    • Valve movement after deployment, blockage or disruption of blood flow through the heart, need for additional heart surgery and possible removal of the SAPIEN 3 valve, a blood clot that requires treatment, damage to the valve (e.g., wear, breakage, recurring aortic stenosis), nonstructural valve dysfunction (e.g., leakage, inappropriate sizing or positioning, blockage, excess tissue in growth, blood cell damage, etc.) or mechanical failure of the delivery system and/or accessories
  • EDWARDS SAPIEN XT TRANSCATHETER HEART VALVE

    Indications: The Edwards SAPIEN XT transcatheter heart valve, model 9300TFX, and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a Heart Team, including a cardiac surgeon, to be at intermediate or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 3% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

    The Edwards SAPIEN XT transcatheter heart valve and accessories are also indicated for patients with symptomatic heart disease due to failure (stenosed, insufficient, or combined) of a surgical bioprosthetic aortic valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., STS operative risk score ≥8% or at a ≥15% risk of mortality at 30 days).

    Contraindications (Who should not use): The Edwards SAPIEN XT transcatheter heart valve and delivery systems should not be used in patients who:

    • Cannot tolerate medications that thin the blood or prevent blood clots from forming.
    • Have an active infection in the heart or elsewhere.

    Warnings:

    • There is a higher risk of stroke in transcatheter aortic valve replacement procedures, compared to balloon aortic valvuloplasty and other standard treatments for aortic stenosis in the high or greater risk population.
    • Implanting a valve that is too small may cause blood leakage and valve movement. Implanting a valve that is too large can cause a buildup of pressure in the valve or a rupture of blood vessels in or around your heart. Your Heart Team will do tests to determine the best valve size for you.
    • The SAPIEN XT valve may not last as long in patients whose bodies do not process calcium normally.
    • Patients should talk to their doctor if they have significant heart disease, a mitral valve device or are allergic to chromium, nickel, molybdenum, manganese, copper, silicon, and/or polymeric materials.
    • During the procedure, your doctors should monitor the dye used in the body; if used in excess it could lead to kidney damage. X-ray guidance used during the procedure may cause injury to the skin, which may be painful, damaging, and long-lasting.
    • Transcatheter aortic heart valve patients should take medications that thin the blood or prevent blood clots from forming, except when likely to have an adverse reaction, as determined by their physician. The Edwards SAPIEN XT transcatheter heart valve has not been tested for use without medications that thin the blood or prevent blood clots from forming.

    Precautions: The long-term durability of the Edwards SAPIEN XT transcatheter heart valve is not known, at this time. Regular medical follow-up is recommended to evaluate how well a patient’s heart valve is performing.

    The safety and effectiveness of implanting:

    • A transcatheter valve inside a transcatheter valve is not known
    • A transcatheter valve inside a surgical tissue valve is not known in the intermediate-risk population

    The safety and effectiveness of the transcatheter heart valve is also not known for patients who have:

    • An aortic heart valve that is not calcified, contains only one or two leaflets, has leaflets with large pieces of calcium that may block the vessels that supply blood to the heart or in which the main problem is that the valve leaks.
    • Previous heart valve replacement or repair
    • A heart that does not pump well, has thickening of the heart muscle, with or without blockage, unusual ultrasound images of the heart that could represent irregularities such as a blood clot, a diseased mitral valve that is calcified or leaking, or Gorlin syndrome, a condition that affects many areas of the body and increases the risk of developing various cancers and tumors
    • Low white, red or platelet blood cell counts, or history of bleeding because the blood does not clot properly
    • Diseased or irregularly shaped vessels leading to the heart. Vessels in the legs which are heavily diseased or too small for associated delivery devices, or a large amount of calcification at the point of entry to the heart, depending on delivery method
    • Allergies to blood-thinning medications or dye injected during the procedure

    Potential risks associated with the procedure include:

    • Death, stroke, paralysis (loss of muscle function), permanent disability, or severe bleeding
    • Risks to the heart, including heart attack or heart failure, a heart that does not pump well, irregular heartbeat that may result in a need for a permanent pace maker, chest pain, heart murmur, false aneurysm, recurring aortic stenosis(narrowing), too much fluid around the heart
    • Risks to your lungs or breathing, including difficulty breathing, fainting, buildup of fluid in or around the lungs, weakness or inability to exercise
    • Risks involving bleeding or your blood supply, including formation of a blood clot, high or low blood pressure, limited blood supply, a decrease in red blood cells, or abnormal lab values, bleeding in the abdominal cavity, collection of blood under the skin
    • Additional risks, including life-threatening infection, dislodgement of calcified material, air embolism (air bubbles in the blood vessels), poor kidney function or failure, nerve injury, fever, allergic reaction to anesthesia or dye, reoperation, pain, infection or bleeding at incision sites, or swelling
    • For a valve in valve procedure, there is a risk of leakage if the previously implanted tissue valve is not securely in place or if it is damaged. There is also the possibility that a partially detached valve leaflet from the previously implanted valve could block a blood vessel. The safety and effectiveness of the transcatheter heart valve has not been determined when the valve is implanted:
      • Inside a stented previously implanted valve smaller than 21 mm
      • Inside an unstented previously implanted aortic tissue valve
    • Your Heart Team will do tests to determine the exact size of the new valve you should receive and communicate what to expect.

    Additional potential risks specifically associated with the use of the heart valve include:

    • Valve movement after deployment, blockage or disruption of blood flow through the heart, sudden loss of heart function, heart failure, need for additional heart surgery and possible removal of the SAPIEN XT valve, a blood clot that requires treatment, damage to the valve (e.g., wear, breakage, recurring aortic stenosis), nonstructural valve dysfunction (e.g., leakage, inappropriate sizing or positioning, blockage, excess tissue ingrowth, blood cell damage, etc.) or mechanical failure of the delivery system and/or accessories

    Be sure to ask your Heart Team to explain your treatment options and the possible benefits and risks of the procedure.

    CAUTION: Federal law (USA) restricts these devices to sale by or on the order of a physician. This information is not a substitute for talking with your doctor.

    Edwards, Edwards Lifesciences, the stylized E logo, Edwards SAPIEN, Edwards SAPIEN XT, Edwards SAPIEN 3, NewHeartValve.com, NewHeartValve.com design logo, SAPIEN, SAPIEN XT, and SAPIEN 3 are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

    © 2016 Edwards Lifesciences Corporation. All rights reserved.